BRPI0815563A2 - Inibidores de akt/pkb com atividade antitumoral - Google Patents
Inibidores de akt/pkb com atividade antitumoralInfo
- Publication number
- BRPI0815563A2 BRPI0815563A2 BRPI0815563-1A2A BRPI0815563A BRPI0815563A2 BR PI0815563 A2 BRPI0815563 A2 BR PI0815563A2 BR PI0815563 A BRPI0815563 A BR PI0815563A BR PI0815563 A2 BRPI0815563 A2 BR PI0815563A2
- Authority
- BR
- Brazil
- Prior art keywords
- akt
- antitumoral activity
- pkb inhibitors
- pkb
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94936507P | 2007-07-12 | 2007-07-12 | |
PCT/US2008/069974 WO2009009793A2 (en) | 2007-07-12 | 2008-07-14 | Inhibitors of akt/pkb with anti-tumor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0815563A2 true BRPI0815563A2 (pt) | 2015-02-18 |
Family
ID=40229514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0815563-1A2A BRPI0815563A2 (pt) | 2007-07-12 | 2008-07-14 | Inibidores de akt/pkb com atividade antitumoral |
Country Status (10)
Country | Link |
---|---|
US (2) | US8183249B2 (pt) |
EP (1) | EP2173352B1 (pt) |
JP (1) | JP5568471B2 (pt) |
KR (1) | KR101618037B1 (pt) |
CN (1) | CN101743007B (pt) |
AU (1) | AU2008274956B2 (pt) |
BR (1) | BRPI0815563A2 (pt) |
CA (1) | CA2695330C (pt) |
MX (1) | MX2010000474A (pt) |
WO (1) | WO2009009793A2 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1786812B1 (en) * | 2004-09-03 | 2011-11-09 | Merck Serono SA | Pyridine methylene azolidinones and their use as phosphoinositide inhibitors |
US8183249B2 (en) * | 2007-07-12 | 2012-05-22 | University Of South Florida | Inhibitors of AKT/PKB with anti-tumor activity |
US8217047B2 (en) | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
US8507496B2 (en) | 2010-09-07 | 2013-08-13 | Dmi Acquisition Corp. | Treatment of diseases |
WO2012158197A2 (en) * | 2010-11-11 | 2012-11-22 | Lyndor Biosciences L.L.C. | Compounds useful as akt/pkb modulators and uses thereof |
ES2768081T3 (es) * | 2011-04-01 | 2020-06-19 | Genentech Inc | Biomarcadores para predecir sensibilidad a tratamientos para el cáncer |
CN103857395A (zh) | 2011-04-01 | 2014-06-11 | 基因泰克公司 | Akt抑制剂化合物和阿比特龙的组合及使用方法 |
CN102225067B (zh) * | 2011-04-29 | 2012-10-03 | 济南环肽医药科技有限公司 | 一种治疗胃癌的药物组合物 |
KR20140075772A (ko) | 2011-10-10 | 2014-06-19 | 앰피오 파마슈티컬스 인코퍼레이티드 | 면역 내성을 증가시킨 이식 의료 장비, 및 그의 제조 및 이식 방법 |
PL2766029T3 (pl) | 2011-10-10 | 2020-08-24 | Ampio Pharmaceuticals, Inc. | Leczenie choroby zwyrodnieniowej stawów |
US10881710B2 (en) | 2011-10-28 | 2021-01-05 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
GB201207722D0 (en) * | 2012-05-02 | 2012-06-13 | Bergenbio As | Method |
KR101461626B1 (ko) * | 2012-08-02 | 2014-11-28 | 서울대학교산학협력단 | Akt1 억제제 및 소수성 항암제를 포함하는 항암용 약학적 조성물 |
WO2014074883A1 (en) * | 2012-11-08 | 2014-05-15 | Lyndor Biosciences L.L.C. | Novel synthesis of ld101 |
KR20150132508A (ko) | 2013-03-15 | 2015-11-25 | 앰피오 파마슈티컬스 인코퍼레이티드 | 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법 |
KR20160099081A (ko) | 2013-07-26 | 2016-08-19 | 업데이트 파마 인코포레이트 | 비산트렌의 치료 효과 개선용 조합 방법 |
US9986375B2 (en) * | 2014-02-12 | 2018-05-29 | Google Llc | Energy-efficient location determination |
CA2958080A1 (en) | 2014-08-18 | 2016-02-25 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
FR3033499A1 (fr) * | 2015-03-11 | 2016-09-16 | Centre Leon-Berard | Composition pour le traitement des tumeurs neuroendocrines pancreatiques |
US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
CN114099681B (zh) * | 2020-12-04 | 2023-03-10 | 周清华 | Akt/stat3作为免疫检查点抑制剂的靶点的用途 |
WO2023168291A1 (en) * | 2022-03-02 | 2023-09-07 | Terremoto Biosciences, Inc. | Covalent modifiers of akt1 and uses thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
US5167649A (en) | 1988-08-22 | 1992-12-01 | Zook Gerald P | Drug delivery system for the removal of dermal lesions |
US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
JP4407008B2 (ja) * | 2000-05-11 | 2010-02-03 | パナソニック株式会社 | カラー画像形成装置 |
UA72612C2 (en) | 2000-07-06 | 2005-03-15 | Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells | |
KR20050006221A (ko) * | 2002-05-06 | 2005-01-15 | 제네랩스 테크놀로지스, 인코포레이티드 | C형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체 |
SI2574341T1 (sl) * | 2004-03-29 | 2017-08-31 | University Of South Florida | Učinkovito zdravljenje tumorjev in raka s triciribin fosfatom |
WO2008094321A2 (en) * | 2006-10-04 | 2008-08-07 | Universtiy Of South Florida | Akt sensitization of cancer cells |
US8183249B2 (en) * | 2007-07-12 | 2012-05-22 | University Of South Florida | Inhibitors of AKT/PKB with anti-tumor activity |
-
2008
- 2008-07-14 US US12/172,831 patent/US8183249B2/en active Active
- 2008-07-14 KR KR1020107002898A patent/KR101618037B1/ko active IP Right Grant
- 2008-07-14 CN CN200880024470.4A patent/CN101743007B/zh not_active Expired - Fee Related
- 2008-07-14 EP EP08772544.6A patent/EP2173352B1/en active Active
- 2008-07-14 AU AU2008274956A patent/AU2008274956B2/en not_active Ceased
- 2008-07-14 CA CA2695330A patent/CA2695330C/en not_active Expired - Fee Related
- 2008-07-14 BR BRPI0815563-1A2A patent/BRPI0815563A2/pt not_active IP Right Cessation
- 2008-07-14 MX MX2010000474A patent/MX2010000474A/es active IP Right Grant
- 2008-07-14 JP JP2010516297A patent/JP5568471B2/ja not_active Expired - Fee Related
- 2008-07-14 WO PCT/US2008/069974 patent/WO2009009793A2/en active Application Filing
-
2012
- 2012-05-21 US US13/476,098 patent/US9359347B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2173352A4 (en) | 2011-07-27 |
AU2008274956A1 (en) | 2009-01-15 |
JP2010533206A (ja) | 2010-10-21 |
WO2009009793A2 (en) | 2009-01-15 |
CN101743007B (zh) | 2015-04-08 |
AU2008274956B2 (en) | 2014-08-21 |
KR101618037B1 (ko) | 2016-05-04 |
JP5568471B2 (ja) | 2014-08-06 |
US20090028855A1 (en) | 2009-01-29 |
WO2009009793A3 (en) | 2009-03-26 |
US20130034598A1 (en) | 2013-02-07 |
KR20100066438A (ko) | 2010-06-17 |
MX2010000474A (es) | 2010-06-23 |
CA2695330C (en) | 2017-06-13 |
CA2695330A1 (en) | 2009-01-15 |
EP2173352A2 (en) | 2010-04-14 |
US8183249B2 (en) | 2012-05-22 |
CN101743007A (zh) | 2010-06-16 |
EP2173352B1 (en) | 2016-09-07 |
US9359347B2 (en) | 2016-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0815563A2 (pt) | Inibidores de akt/pkb com atividade antitumoral | |
BRPI0807146A2 (pt) | Inibidores da atividade da akt | |
CR10851A (es) | Inhibidores de la actividad de la akt | |
BRPI0820544A2 (pt) | 4-pirazolil-n-arilpirimidin-2-aminas e pirazolil-n-heteroarilpirimidin-2-aminas como inibidores de janus cinase | |
EP2303269A4 (en) | HAMMER OF ACT ACTIVITY | |
BRPI0917980A2 (pt) | subcanalização com aumento de potência | |
DK2114477T3 (da) | Hydrofil coating | |
BRPI0911175A2 (pt) | conjuntos de válvula | |
BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
EP2114388A4 (en) | INHIBITORS OF AKT'S ACTIVITY | |
BRPI0811044A2 (pt) | 2-morfolin-4-il-pirimidinas como inibidores de p13k. | |
DK2358710T3 (da) | AKT- og P70-S6-kinaseinhibitorer | |
IL209488A0 (en) | Inhibitors of akt activity | |
EP2134175A4 (en) | HAMMER OF ACT ACTIVITY | |
EP2306825A4 (en) | HAMMER OF ACT ACTIVITY | |
EP2303852A4 (en) | ACTIVITY INHIBITORS AKT | |
BRPI0917982A2 (pt) | composição de alvejamento particulada que compreende enzimas | |
BRPI0922832A2 (pt) | nonapeptídeo com atividade antitumor | |
BRPI0716198A2 (pt) | Pirrolo-isoquinolinas como inibidores de cinase | |
EP2120951A4 (en) | INHIBITORS OF AKT ACTIVITY | |
BRPI0906798A2 (pt) | Pirimidil ciclopentanos hidroxilados como inibidores de proteína quinase akt | |
BRPI0907372A2 (pt) | Pirimidil ciclopentano hidroxilado como inibidor de proteína quinase akt | |
DK2091536T3 (da) | Enantiomere forbindelser med antibakteriel aktivitet | |
BRPI0914936A2 (pt) | naftiridininonas como inibidores de aurora quinase | |
EP2303277A4 (en) | HAMMER OF ACT ACTIVITY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2523 DE 14-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |